Capra Biosciences

Capra Biosciences is a venture-backed startup company based in Manassas, VA, focused on revolutionizing chemical production through sustainable means. Their patented bioreactor technology utilizes a metabolically flexible, biofilm-forming bacteria to transform waste into valuable materials. This innovative approach allows for the cost-efficient and sustainable production of high-performance renewable chemicals, making them a strong contender in the green chemistry field.

Capra's mission is to make high-performance renewable chemicals both cost-efficient and sustainable. Their first product, a 100% petroleum-free Retinol, demonstrates their platform's potential for creating high-value products. They are currently working on a $7.5 million project to demonstrate the scalability of their platform for manufacturing active pharmaceutical ingredients (APIs), aiming to address the issue of pharmaceutical ingredient shortages in the United States.

The company's website mentions that full-time opportunities at Capra Biosciences come with a competitive salary, benefits package including company stock options and medical, dental, and vision coverage for employees and dependents, 15 paid vacation days and 10 paid holidays per year. The company also seeks innovative individuals excited to work at the interface of biology and hardware engineering. There is no mention of remote work or flexible schedules, so the company likely offers traditional full-time employment.

Capra Biosciences offers a competitive salary and a benefits package that includes company stock options, medical, dental, and vision healthcare coverage for both employees and their dependents, 15 paid vacation days, and 10 paid holidays per year.

Capra Biosciences is a venture-backed startup company revolutionizing chemical production with its patented bioreactor technology. Their mission is to make high-performance renewable chemicals cost-efficient and sustainable by using natural processes to consume and transform waste into valuable materials. Capra's bioreactor platform leverages biofilm-forming bacteria to create a variety of chemicals, including their first commercial product, retinol, and they are currently working on scaling up production of active pharmaceutical ingredients to address the issue of pharmaceutical ingredient shortages.

Capra Biosciences promotes a culture of innovation and collaboration, valuing individuals who are excited to work at the interface of biology and hardware engineering. They are a venture-backed startup company dedicated to sustainable production, fostering an environment where creative problem-solving and a commitment to making a positive impact on the world are highly valued.